Click here to know more on the issue
Why in news?
Recently, the Supreme Court has restored US-based Monsanto Technology’s patent on technology used in Bt Cotton seeds.
Why is the matter in court?
- The case relates to a dispute between Monsanto and Nuziveedu Seeds Ltd over the technology.
- A 10-year sub-licence agreement was made between the two companies in 2004.
- Under that, Nuziveedu could develop “Genetically Modified Hybrid Cotton Planting Seeds” with the help of Monsanto technology and commercially exploit it.
- In return, Nuziveedu had to pay licence fee/trait value.
- Monsanto terminated the agreement in 2015, with disputes having arisen over these payments amid a price control regime introduced by the government.
- Monsanto filed a civil suit in Delhi High Court, claiming that Nuziveedu Seeds was infringing on its patent by using its technology.
- It also filed an application for injunction to restrain Nuziveedu from using the Monsanto trademark during the pendency of the civil suit.
- Nuziveedu filed a counter-claim against Monsanto’s patent claim in the High court.
What has Monsanto’s argument been in this case?
- In the present suit, there are two sets of patent claims — claims 1-24 relating to processes, and claims 25-27 relating to the chemical product NAS (Nucleic Acid Sequence).
- Monsanto has claimed that NAS is a man-made DNA construct and not part of a plant existing in nature.
- The DNA construct is inserted into a plant “which confers the trait of insect tolerance”.
- When it is inserted into the cell of the plant at a particular location, it results in the production of a fusion protein.
- Monsanto’s argument is that the production of the fusion protein is critical for the technology to be effected and it is only its technology that allows a cotton plant to produce it.
- Thus, the product is protected by claims 25-27 of the patented inventions.
What has Nuvizeedu’s argument been in this case?
- Nuziveedu focused on Section 3 (j) of the Patent Act, 1970, which served as the main ground for the revocation of the mentioned Patent.
- It contended that, under Section 3(j) - Plants and animals, other than microorganisms, including seeds, varieties and species and essentially biological processes for production or propagation of plants and animals are not inventions.
- Thus, claim 25 of the Patent relates to ‘nucleic acid sequence’, is equated in terms of “a plant cell, a seed, a transgenic plant or a plant variety”.
- Hence it is not considered as inventions and cannot be granted a patent in India.
- Further, Nuziveedu contended that Bt. Trait in Cotton Hybrid varietal plants is an essential biological process.
- Cross-bred plants and animals are not patentable because they are better regarded as discoveries which happens naturally and therefore, it’s just a discovery which has taken place in a laboratory.
- It has also argued that its rights are protected under the Protection of Plant Varieties and Farmers’ Rights Act, 2001.
What happens now?
- The Delhi High had passed two separate orders in this case.
- The First order ruled that during the pendency of the case, both parties would have to abide by obligations under their agreement.
- Also, Nuziveedu Seeds should pay licence fees in accordance with the regulatory requirement.
- In the second order, the high court ruled that Monsanto’s patent claim was invalidated under Section 3(j) of the Patents Act.
- However, the Supreme Court recently overturned this judgement saying that Monsanto can claim patents on its genetically modified (GM) cotton seeds.
- Thus, the SC ruling restores the first order of the High court and hence the same bench of the HC will now hear the matter of patentability on this case.
Source: The Indian Express
